Just 18% of People Who Need Lung Cancer Screening Get It

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 10, 2024.

By Carole Tanzer Miller HealthDay Reporter

MONDAY, June 10, 2024 -- Only a fraction of Americans are getting recommended lung cancer screenings, new research shows.

While rates overall are up slightly, fewer than 1 in 5 people who are eligible for screening are up-to-date with it, according to the American Cancer Society-led study.

The society and the U.S. Preventive Services Task Force recommend a yearly computed tomography (CT) scan for people who are at high risk for lung cancer. Those include current smokers between the ages of 50 and 80 as well as those who quit less than 15 years ago.

"We, clearly, still have a long way to go," said Priti Bandi, scientific director of cancer risk factors and screening surveillance research at the American Cancer Society (ACS).

She said screening is critical because lung cancer often has no symptoms in the early stages. "When diagnosed and treated early, survival is markedly improved," Bandi added in an ACS news release.

For the study, researchers analyzed data from close to 26,000 Americans who were eligible for lung cancer screening. More than 61% were smokers, 54% were men and 64% were over 60. Nearly 8 in 10 were white people.

Overall, 18% had been screened for lung cancer. Rates varied from state to state, with lower rates in the South, where seven states have not expanded eligibility for Medicaid.

Screening rates rose with age — from 6.7% for folks in their early 50s to 27.1% among those in their 70s.

One in 20 people who were uninsured or who didn't have a usual source of care had not been screened. Screening rates were higher in states that have expanded eligibility for Medicaid coverage.

The findings were published June 10 in the journal JAMA Internal Medicine.

"This research further amplifies the critical need for reducing all barriers to access to care, to ensure people are able to immediately utilize preventive and early detection screenings at no cost," said Lisa Lacasse, president of the American Cancer Society Action Network.

"Expanding Medicaid in the 10 states that have yet to do so would significantly improve access to these lifesaving screenings and decrease lung cancer deaths, as well as eliminating patient costs for screening and follow-up tests," she added.

Sources

  • American Cancer Society, news release, June 10, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-06-11 16:47

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords